The introduction in clinical Cardiology of Cardiac Magnetic Resonance Imaging has opened extraordinary opportunities both for the understanding and the treatment of a large variety of cardiac diseases.

In fact, Cardiac Magnetic Resonance Imaging can be considered, at all the effects, a sort of Cardiac Pathology in vivo and, because of this potential, is nowadays considered essential for the management of some cardiac diseases. A unique potential of Cardiac Magnetic Resonance Imaging is represented by the capacity of identifying the myocardial substrate for arrhythmias in a large variety of diseases characterized by the presence of severe, sometimes lethal, ventricular arrhythmias.

In the symposium on “International Symposium on: “Substrates Analysis and Therapy in Arrhythmogenic Cardiomyopathies: The role of CMR” internationally recognized experts will discuss the potential and the clinical role of Cardiac Magnetic Resonance Imaging in those diseases that more than others have been the object of systematic research. The clinical impact of Cardiac Magnetic Resonance Imaging in these specific contexts will also be discussed.